Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 65076 - 65100 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	GALNT4	8693	upregulated	resveratrol results in increased expression of GALNT4 mRNA	12q21.33	A22289
Resveratrol	Investigational	GAP43	2596	downregulated	resveratrol results in decreased expression of GAP43 mRNA	3q13.31	A22498
Resveratrol	Investigational	GAST	2520	downregulated	resveratrol results in decreased expression of GAST mRNA	17q21.2	A23893
Resveratrol	Investigational	GCK	2645	upregulated	resveratrol results in increased expression of GCK mRNA	7p13	A23945
Resveratrol	Investigational	GCLC	2729	upregulated	[resveratrol results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA	6p12.1	A23946
Resveratrol	Investigational	GCLC	2729	upregulated	resveratrol results in increased expression of GCLC mRNA	6p12.1	A23029 A23947 A23946
Resveratrol	Investigational	GDF1	2657	downregulated	resveratrol results in decreased expression of GDF1 mRNA	19p13.11	A22498
Resveratrol	Investigational	GDF15	9518	upregulated	resveratrol results in increased expression of GDF15 mRNA	19p13.11	A23948 A23908
Resveratrol	Investigational	GDPD5	81544	upregulated	resveratrol results in increased expression of GDPD5 mRNA	11q13.4-q13.5	A22289
Resveratrol	Investigational	GFRA2	2675	downregulated	resveratrol results in decreased expression of GFRA2 mRNA	8p21.3	A23859
Resveratrol	Investigational	GINS1	9837	upregulated	resveratrol results in increased expression of GINS1 mRNA	20p11.21	A21103
Resveratrol	Investigational	GJB2	2706	upregulated	resveratrol results in increased expression of GJB2 mRNA	13q12.11	A23852
Resveratrol	Investigational	GLRX2	51022	upregulated	resveratrol results in increased expression of GLRX2 mRNA	1q31.2	A22289
Resveratrol	Investigational	GNB1	2782	downregulated	resveratrol results in decreased expression of GNB1 mRNA	1p36.33	A21103
Resveratrol	Investigational	GPC6	10082	downregulated	resveratrol results in decreased expression of GPC6 mRNA	13q31.3-q32.1	A23852
Resveratrol	Investigational	GPLD1	2822	downregulated	resveratrol results in decreased expression of GPLD1 mRNA	6p22.3	A22498
Resveratrol	Investigational	GPR142	350383	upregulated	resveratrol results in increased expression of GPR142 mRNA	17q25.1	A22289
Resveratrol	Investigational	GPRIN1	114787	upregulated	resveratrol results in increased expression of GPRIN1 mRNA	5q35.2	A23845
Resveratrol	Investigational	GPSM2	29899	upregulated	resveratrol results in increased expression of GPSM2 mRNA	1p13.3	A21103
Resveratrol	Investigational	GPX1	2876	upregulated	resveratrol results in increased expression of GPX1 mRNA	3p21.31	A23872 A23949
Resveratrol	Investigational	GPX2	2877	upregulated	resveratrol results in increased expression of GPX2 mRNA	14q23.3	A21823
Resveratrol	Investigational	GRB10	2887	upregulated	resveratrol results in increased expression of GRB10 mRNA	7p12.1	A21310
Resveratrol	Investigational	GRB2	2885	downregulated	resveratrol results in decreased expression of GRB2 mRNA	17q25.1	A22498
Resveratrol	Investigational	GREB1	9687	upregulated	resveratrol results in increased expression of GREB1 mRNA	2p25.1	A21295
Resveratrol	Investigational	GRINA	2907	upregulated	resveratrol results in increased expression of GRINA mRNA	8q24.3	A23908

Displaying entries 65076 - 65100 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability